Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study

HER2-positive breast cancer (HER2 BC) is an aggressive subtype, with neoadjuvant treatment (NAT) aiming to achieve a pathological complete response (pCR) to improve long-term outcomes. Trastuzumab emtansine (T-DM1) has been established as the standard of care in the adjuvant setting for HER2 BC pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2024-12, Vol.16 (23), p.4104
Hauptverfasser: Krasniqi, Eriseld, Filomeno, Lorena, Arcuri, Teresa, Di Lisa, Francesca Sofia, Astone, Antonio, Cutigni, Claudia, Foglietta, Jennifer, Nunzi, Martina, Rossi, Rosalinda, Minelli, Mauro, Meattini, Icro, Visani, Luca, Scialino, Jacopo, Livi, Lorenzo, Moscetti, Luca, Marchetti, Paolo, Botticelli, Andrea, Paris, Ida, Pavese, Francesco, D'Angelo, Tatiana, Sini, Valentina, Stani, Simonetta, Valerio, Maria Rosaria, Grassadonia, Antonino, Tinari, Nicola, Mazzotta, Marco, Vergati, Matteo, D'Auria, Giuliana, Gamucci, Teresa, D'Onofrio, Loretta, Gasparro, Simona, Roselli, Arianna, Fulvi, Alberto, Ferretti, Gianluigi, Torchia, Andrea, Giordano, Monica, Greco, Filippo, Pantano, Francesco, Tonini, Giuseppe, Fabbri, Agnese, Bria, Emilio, Garufi, Giovanna, Fiorio, Elena, Raffaele, Mimma, Pistelli, Mirco, Berardi, Rossana, Saltarelli, Rosa, Kayal, Ramy, Ferranti, Francesca Romana, Cannita, Katia, Irelli, Azzurra, D'Ostilio, Nicola, De Rossi, Costanza, Palumbo, Raffaella, Cariello, Anna, Sanguineti, Giuseppe, Calabrò, Fabio, Pizzuti, Laura, Barba, Maddalena, Botti, Claudio, Pelle, Fabio, Cappelli, Sonia, Cavicchi, Flavia, Puccica, Ilaria, Villanucci, Amedeo, Sperduti, Isabella, Ciliberto, Gennaro, Vici, Patrizia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!